BR9808923B1 - processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2. - Google Patents
processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.Info
- Publication number
- BR9808923B1 BR9808923B1 BRPI9808923-4A BR9808923A BR9808923B1 BR 9808923 B1 BR9808923 B1 BR 9808923B1 BR 9808923 A BR9808923 A BR 9808923A BR 9808923 B1 BR9808923 B1 BR 9808923B1
- Authority
- BR
- Brazil
- Prior art keywords
- cyclooxygenase
- making
- compounds
- inhibitors
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/52—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4564297P | 1997-04-18 | 1997-04-18 | |
GBGB9709686.1A GB9709686D0 (en) | 1997-05-13 | 1997-05-13 | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
PCT/US1998/008312 WO1998047871A1 (en) | 1997-04-18 | 1998-04-14 | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9808923A BR9808923A (pt) | 2000-08-01 |
BR9808923B1 true BR9808923B1 (pt) | 2010-08-24 |
Family
ID=26311530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9808923-4A BR9808923B1 (pt) | 1997-04-18 | 1998-04-14 | processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0975596B1 (pt) |
JP (1) | JP3300369B2 (pt) |
KR (1) | KR20010006546A (pt) |
CN (1) | CN1182117C (pt) |
AT (1) | ATE270275T1 (pt) |
AU (1) | AU729730B2 (pt) |
BR (1) | BR9808923B1 (pt) |
CA (1) | CA2287482C (pt) |
CZ (1) | CZ293246B6 (pt) |
DE (1) | DE69824839T2 (pt) |
EA (1) | EA002190B1 (pt) |
ES (1) | ES2223128T3 (pt) |
HK (1) | HK1023771A1 (pt) |
HR (1) | HRP980206B1 (pt) |
HU (1) | HU226999B1 (pt) |
NZ (1) | NZ500390A (pt) |
PL (1) | PL190265B1 (pt) |
RS (1) | RS49901B (pt) |
SK (1) | SK285037B6 (pt) |
TW (1) | TW492959B (pt) |
UA (1) | UA66792C2 (pt) |
WO (1) | WO1998047871A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100446324B1 (ko) * | 1999-01-14 | 2004-08-30 | 론자 아게 | 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법 |
SK284903B6 (sk) * | 1999-01-14 | 2006-02-02 | Lonza Ag | Spôsob výroby 1-(6-metylpyridín-3-yl)-2-[(4- (metylsulfonyl)fenyl]etanónu a medziprodukty |
US6566527B1 (en) | 1999-07-27 | 2003-05-20 | Merck & Co., Inc. | Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone |
DK1198455T3 (da) * | 1999-07-27 | 2004-04-05 | Lonza Ag | Fremgangsmåde til fremstilling af 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulfonyl)phenyl]ethanon |
KR20020067574A (ko) | 1999-12-23 | 2002-08-22 | 니트로메드 인코포레이티드 | 니트로소화 및 니트로실화된 사이클로옥시게나아제-2억제제, 조성물 및 그 이용방법 |
JP2001261647A (ja) * | 2000-03-22 | 2001-09-26 | Sankio Chemical Co Ltd | ピリジン誘導体の製造方法 |
ES2290157T3 (es) | 2000-07-20 | 2008-02-16 | Lauras As | Uso de inhibidores de cox-2 como inmunoestimulantes en el tratamiento de vih o sida. |
ES2683125T3 (es) * | 2010-06-16 | 2018-09-25 | Glenmark Generics Limited | Proceso para la preparación de piridinas 2,3-diaril-5-sustituidas y sus compuestos intermedios |
ES2603640T3 (es) * | 2010-11-15 | 2017-02-28 | Virdev Intermediates Pvt. Ltd. | Un proceso para inhibidor selectivo de ciclooxigenasa-2 |
CN103204803A (zh) | 2012-01-13 | 2013-07-17 | 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 | 用于合成依托考昔的方法 |
WO2014114352A1 (en) * | 2013-01-25 | 2014-07-31 | Synthon Bv | Process for making etoricoxib |
WO2015036550A1 (en) | 2013-09-13 | 2015-03-19 | Synthon B.V. | Process for making etoricoxib |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH561716A5 (pt) * | 1971-05-10 | 1975-05-15 | Ciba Geigy Ag | |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5686470A (en) * | 1995-02-10 | 1997-11-11 | Weier; Richard M. | 2, 3-substituted pyridines for the treatment of inflammation |
RU2200158C2 (ru) * | 1995-02-13 | 2003-03-10 | Джи.Ди.Сирл энд Ко. | Замещенные изоксазолы, фармацевтические композиции на их основе и способ подавления воспалений |
US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
EP0912518B1 (en) * | 1996-07-18 | 2003-09-10 | Merck Frosst Canada & Co. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
-
1998
- 1998-04-09 TW TW087105349A patent/TW492959B/zh not_active IP Right Cessation
- 1998-04-14 CA CA002287482A patent/CA2287482C/en not_active Expired - Fee Related
- 1998-04-14 NZ NZ500390A patent/NZ500390A/en unknown
- 1998-04-14 CZ CZ19993690A patent/CZ293246B6/cs not_active IP Right Cessation
- 1998-04-14 SK SK1436-99A patent/SK285037B6/sk not_active IP Right Cessation
- 1998-04-14 ES ES98919881T patent/ES2223128T3/es not_active Expired - Lifetime
- 1998-04-14 PL PL98336298A patent/PL190265B1/pl not_active IP Right Cessation
- 1998-04-14 AU AU72571/98A patent/AU729730B2/en not_active Ceased
- 1998-04-14 DE DE69824839T patent/DE69824839T2/de not_active Expired - Lifetime
- 1998-04-14 BR BRPI9808923-4A patent/BR9808923B1/pt not_active IP Right Cessation
- 1998-04-14 JP JP54636798A patent/JP3300369B2/ja not_active Expired - Fee Related
- 1998-04-14 KR KR1019997009636A patent/KR20010006546A/ko not_active IP Right Cessation
- 1998-04-14 HU HU0003155A patent/HU226999B1/hu not_active IP Right Cessation
- 1998-04-14 WO PCT/US1998/008312 patent/WO1998047871A1/en active IP Right Grant
- 1998-04-14 EA EA199900948A patent/EA002190B1/ru not_active IP Right Cessation
- 1998-04-14 EP EP98919881A patent/EP0975596B1/en not_active Expired - Lifetime
- 1998-04-14 CN CNB988061864A patent/CN1182117C/zh not_active Expired - Fee Related
- 1998-04-14 RS YUP-536/99A patent/RS49901B/sr unknown
- 1998-04-14 AT AT98919881T patent/ATE270275T1/de not_active IP Right Cessation
- 1998-04-14 UA UA99116266A patent/UA66792C2/uk unknown
- 1998-04-16 HR HR980206A patent/HRP980206B1/xx not_active IP Right Cessation
-
2000
- 2000-05-16 HK HK00102924A patent/HK1023771A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU64100A (sh) | Postupak za sintetizovanje cox-2 inhibitora | |
BR9812837A (pt) | Processo para fazer um composto, e, composto | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
UA49809C2 (uk) | Спосіб одержання фенільних гетероциклів, які використовуються як інгібітори цог-2, а також сполуки, одержані цим способом | |
WO2002030353A3 (en) | NF-λB INHIBITORS | |
TW200510397A (en) | Conjugated complement cascade inhibitors | |
BR0008625A (pt) | Processo para tratamento de asma induzida por exercìcio | |
BR9808923B1 (pt) | processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2. | |
AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
ATE193526T1 (de) | Alkylierte styrole als prodrugs zu cox-2- inhibitoren | |
DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer | |
NO20033921L (no) | Inhibitor av monoaminopptak | |
PL330227A1 (en) | Method of obtaining phenylheterocyclic compounds suitable as cox-2 inhibitors | |
DE69930844D1 (de) | Inhibitoren von mycobakterien | |
DE60010934D1 (de) | Medikamente geeignet zur Behandlung von proliferativen Erkrankungen | |
ATE409066T1 (de) | Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit | |
MY140504A (en) | Statin-mmp inhibitor combinations | |
WO1999025327A3 (en) | Small molecule intervention in hiv-1 replication | |
EP1351680B8 (fr) | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament | |
DK1366033T3 (da) | Kemiske forbindelser | |
DK0971714T3 (da) | Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens | |
DE60215947D1 (de) | Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht | |
PT1315491E (pt) | Utilizacao de pirazoles substituidos para o fabrico de um medicamento para o tratamento de alergias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/08/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved |
Owner name: MERCK SHARP AND DOHME CORP. (US) Free format text: NOME ALTERADO DE: MERCK AND CO., INC. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 15A, 16A E 17A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |